Clinical Trial Update: Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease

View source ↗

Summary

Clinical trial update reports improved myocardial blood flow with phosphodiesterase-5 inhibition in patients with coronary artery disease and therapy-refractory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Therapy Refractory Myocardial Ischemia

Drugs mentioned

• PDE5 inhibitor

Snippet

Sponsor: Medical University of Vienna | Conditions: Therapy Refractory Myocardial Ischemia, Coronary Artery Disease | Status: TEMPORARILY_NOT_AVAILABLE